OptimizeRx stock is back in focus after analysts reaffirmed a fair value estimate of about $24.33 per share, even as a slightly higher discount rate reflects a modest uptick in perceived risk. The ...
Model Personalization - a series of tools for developing a personalized neuromusculoskeletal model to improve the accuracy and physical significance of the joints, muscles, synergies, and ground ...
An illustration of a magnifying glass. An illustration of a magnifying glass.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback